$145.75
15271 reports the primary application service for qualifying wounds on the trunk, arms, or legs; Q4154 identifies the Biovance product used with that service.
On this page
CMS RVU26D · Effective 2026-10-01
Q4154 Wound matrix Medicare reimbursement rates in Nebraska
Reports Biovance amniotic membrane used as a wound covering, with units based on the product amount and billing paired with a primary application procedure. Compare Q4154 office and facility rates across CMS payment localities in Nebraska.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4154 in Nebraska?
Nebraska has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$117.46
1 of 1 localities have a supported rate.
Payment area: Nebraska
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Skin substitute product
About Q4154: Biovance amniotic membrane product
Reports Biovance amniotic membrane used as a wound covering, with units based on the product amount and billing paired with a primary application procedure.
Q4154 identifies Biovance, a dehydrated human amniotic membrane allograft used as a biologic covering in wound care. Wound-care clinicians and surgeons may apply it to cutaneous wounds, including diabetic foot or venous leg ulcers, in settings where wound treatment is performed. This code represents the product, measured in one-square-centimeter units; it is not the application procedure itself.
Report Q4154 with the primary procedure for applying the skin substitute, using the documented product amount and the appropriate application code for the wound site and area. The record should identify Biovance, the treated wound, and the amount used. CMS classifies Q4154 as an add-on: it is billed only with a primary procedure and paid within that procedure’s global period. It is technical-component-only; interpretation is represented by a separate code.
CMS billing rules for Q4154
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4154 compared with similar codes
Office rates for Nebraska, from the same CMS release.
$148.92
15275 is a primary application procedure for qualifying wounds at specified special sites. Q4154 reports the Biovance product, not the site-specific application.
$117.46
Q4152 identifies Dermapure, while Q4154 identifies Biovance. Choose the product code that matches the wound covering actually used.
Compare Q4154 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Nebraska →
Office / nonfacility
$117.46
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4154 in Nebraska.
PPRRVU2026_Oct_nonQPP.csv
18,247
- Code
- Q4154
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
72
- Locality
- Nebraska
- Physician work
- 1.000
- Practice expense
- 0.923
- Malpractice
- 0.378
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 0.923 | 3.5166 |
| Malpractice | 0.00 | × 0.378 | 0.0000 |
| Total RVUs | 3.5166 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Nebraska$117.46
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 0.923 |
| Malpractice | 0 | 0.378 |
(0 × 1 + 3.81 × 0.923 + 0 × 0.378) × $33.4009 = $117.46
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4154 billing questions
Is Q4154 the code for applying the wound covering?
No. Q4154 identifies the Biovance product per square centimeter. Report the appropriate primary skin-substitute application procedure separately.
What primary procedure is reported with Q4154?
Pair it with the application code selected for the wound site and total treated area. For example, 15271 is a primary application code for qualifying wounds on the trunk, arms, or legs.
How are Q4154 units determined?
Each unit represents one square centimeter of Biovance. Document the product amount used so the billed units can be supported.
Does Q4154 include interpretation?
No. CMS classifies it as technical-component-only; a separate code covers interpretation.
Can Q4154 be billed by itself?
No. CMS identifies it as an add-on that must be billed with a primary procedure and is paid within that procedure’s global period.
What documentation supports reporting Q4154?
Document that Biovance was used, the wound treated, and the product amount in square centimeters, along with the primary application procedure.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
18,244Q4151,,"Amnioband, guardian 1 sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,245Q4152,,Dermapure 1 square cm,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,246Q4153,,"Dermavest, plurivest sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,247Q4154,,Biovance 1 square cm,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,248Q4155,,Neoxflo or clarixflo 1 mg,C,,0.00,0.00,,0.00,,0.00,0.00,0.00,3,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
18,249Q4156,,Neox 100 or clarix 100,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,250Q4157,,Revitalon 1 square cm,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
6905302,MO,01,METROPOLITAN ST. LOUIS,1.000,0.952,1.002
7005302,MO,99,REST OF MISSOURI,1.000,0.862,0.974
7103202,MT,01,MONTANA**,1.000,1.000,0.998
7205402,NE,00,NEBRASKA,1.000,0.923,0.378
7301312,NV,00,NEVADA**,1.000,1.001,0.833
7414312,NH,40,NEW HAMPSHIRE,1.000,1.041,0.875
7512402,NJ,01,NORTHERN NJ,1.063,1.160,1.068